ASIA-PACIFIC DRUG DISCOVERY MARKET 2019-2027


MARKET OUTLOOK
As per a Triton Market Research report, the Asia-Pacific drug discovery market is showcasing steady growth at a CAGR of 8.67% over the forecasted years 2019-2027 in terms of revenue.
China, Japan, India, South Korea, Australia, and Rest of APAC are the countries that form the drug discovery market in the region.
The Asia-Pacific region is predicted to be the fastest-growing region in the drug discovery market during the forecasted period. Different healthcare organizations across the globe have been planning to set up businesses in Asian countries. The rising technological innovations and the application of small molecule drugs for treating chronic disorders are primarily fueling the demand for various drugs. This is expected to boost the drug discovery market in the Asia-Pacific.
In South Korea, several contract research organizations (CROs) are actively working in ongoing drug discovery programs, such as those for curing various types of cancer, neurological & metabolic diseases, and bacterial infections. For instance, the new anti-cancer drug has been developed with Bionetix, a South Korean biotechnology company, through its collaborative research programs. Also, Celerion and the Korean Drug Development Fund (KDDF) have made a partnership to support the development of the drug discovery market in South Korea. Moreover, many new approaches considering proteomics, genomics and bioinformatics technologies have been developed, which would offer lucrative opportunities for the growth of the drug discovery market.
COMPETITIVE OUTLOOK
Becton, Dickinson and Company (BD), Antares Pharma, Inc., Eli Lily and company, Johnson and Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Bayer AG, Merck & Co. Inc., and Boehringer Ingelheim are some of the noted players in the drug discovery market.
TABLE OF CONTENTS 
1. ASIA-PACIFIC DRUG DISCOVERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. PORTER’S FIVE FORCES MODEL
2.2.1. THREATS OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. COMPETITIVE RIVALRY
2.3. PESTLE OUTLOOK
2.4. REGULATORY FRAMEWORK
2.5. VALUE CHAIN OUTLOOK
2.6. MARKET ATTRACTIVENESS INDEX
2.7. KEY INSIGHT
2.8. MARKET DRIVERS
2.8.1. GROWING AGED POPULATION
2.8.2. TECHNOLOGICAL ADVANCEMENTS
2.8.3. RISE IN THE HEALTHCARE EXPENDITURE
2.8.4. SURGE IN LIFESTYLE-ORIENTED DISEASES
2.9. MARKET RESTRAINTS
2.9.1. DELAY IN PRODUCT LAUNCHES
2.9.2. RESTRICTING GROWTH RATE OF A DRUG DUE TO GENERIC DRUGS
2.10. MARKET OPPORTUNITIES
2.10.1. SIGNIFICANT INVESTMENT BY HEALTHCARE INDUSTRIES IN IMPROVING BIG-DATA ANALYTICAL CAPABILITIES
2.10.2. RISING DEMAND FOR SPECIALTY MEDICINES
2.11. MARKET CHALLENGES
2.11.1. POOR REIMBURSEMENTS POLICIES IN EMERGING NATIONS
2.11.2. STRINGENT GOVERNMENT REGULATIONS
3. DRUG DISCOVERY MARKET OUTLOOK – BY DRUG TYPE
3.1. SMALL MOLECULE DRUG
3.2. BIOLOGIC DRUG
4. DRUG DISCOVERY MARKET OUTLOOK – BY TECHNOLOGY
4.1. HIGH THROUGHPUT SCREENING
4.2. BIOCHIPS
4.3. BIOINFORMATICS
4.4. PHARMACOGENOMICS AND PHARMACOGENETICS
4.5. COMBINATORIAL CHEMISTRY
4.6. NANOTECHNOLOGY
4.7. SPECTROSCOPY
4.8. METABOLOMICS
4.9. OTHER TECHNOLOGIES
5. DRUG DISCOVERY MARKET OUTLOOK – BY SERVICE
5.1. DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
5.2. CHEMICAL SERVICES
5.3. BIOLOGICAL SERVICES
5.4. OTHER PHARMACEUTICAL SERVICES
6. DRUG DISCOVERY MARKET OUTLOOK – BY END-USER
6.1. RESEARCH INSTITUTES
6.2. PHARMACEUTICAL COMPANIES
6.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
6.4. OTHER END-USERS
7. DRUG DISCOVERY MARKET – REGIONAL OUTLOOK
7.1. ASIA-PACIFIC
7.1.1. COUNTRY ANALYSIS
7.1.1.1. CHINA
7.1.1.2. INDIA
7.1.1.3. JAPAN
7.1.1.4. SOUTH KOREA
7.1.1.5. AUSTRALIA & NEW ZEALAND
7.1.1.6. ASEAN COUNTRIES
7.1.1.7. REST OF ASIA-PACIFIC
8. COMPANY PROFILES
8.1. 3M COMPANY
8.2. ABBOTT LABORATORIES INC.
8.3. AGILENT TECHNOLOGIES, INC.
8.4. ANTARES PHARMA
8.5. ASTRAZENECA PLC
8.6. BAYER AG
8.7. BECTON, DICKINSON AND COMPANY (BD)
8.8. BOEHRINGER INGELHEIM
8.9. ELI LILY AND COMPANY
8.10. F. HOFFMANN-LA ROCHE LTD.
8.11. GLAXOSMITHKLINE LLC
8.12. JOHNSON & JOHNSON
8.13. MERCK & CO., INC.
8.14. NOVARTIS
8.15. PFIZER, INC.
8.16. SANOFI
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS
 
LIST OF TABLES 
TABLE 1 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
TABLE 2 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION)
TABLE 3 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
TABLE 4 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION)
TABLE 5 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY END-USER, 2019-2027 ($ MILLION)
TABLE 6 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
 
  
LIST OF FIGURES 
FIGURE 1 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 2 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION)
FIGURE 3 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION)
FIGURE 4 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION)
FIGURE 5 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION)
FIGURE 6 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION)
FIGURE 7 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION)
FIGURE 8 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION)
FIGURE 9 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION)
FIGURE 10 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION)
FIGURE 11 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION)
FIGURE 12 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION)
FIGURE 13 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION)
FIGURE 14 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 15 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 16 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION)
FIGURE 17 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
FIGURE 18 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION)
FIGURE 19 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION)
FIGURE 20 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2027 ($ MILLION)
FIGURE 21 CHINA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 22 INDIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 23 JAPAN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 24 SOUTH KOREA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 25 AUSTRALIA & NEW ZEALAND DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 26 ASEAN COUNTRIES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)
FIGURE 27 REST OF ASIA-PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

LIST OF TABLES TABLE 1 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) TABLE 2 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG TYPE, 2019-2027 ($ MILLION) TABLE 3 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION) TABLE 4 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SERVICE, 2019-2027 ($ MILLION) TABLE 5 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY END-USER, 2019-2027 ($ MILLION) TABLE 6 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COUNTRY, 2019-2027 ($ MILLION) LIST OF FIGURES FIGURE 1 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 2 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SMALL MOLECULE DRUG, 2019-2027 ($ MILLION) FIGURE 3 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGIC DRUG, 2019-2027 ($ MILLION) FIGURE 4 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 ($ MILLION) FIGURE 5 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOCHIPS, 2019-2027 ($ MILLION) FIGURE 6 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOINFORMATICS, 2019-2027 ($ MILLION) FIGURE 7 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY PHARMACOGENOMICS AND PHARMACOGENETICS, 2019-2027 ($ MILLION) FIGURE 8 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY COMBINATORIAL CHEMISTRY, 2019-2027 ($ MILLION) FIGURE 9 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY NANOTECHNOLOGY, 2019-2027 ($ MILLION) FIGURE 10 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY SPECTROSCOPY, 2019-2027 ($ MILLION) FIGURE 11 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY METABOLOMICS, 2019-2027 ($ MILLION) FIGURE 12 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER TECHNOLOGIES, 2019-2027 ($ MILLION) FIGURE 13 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, 2019-2027 ($ MILLION) FIGURE 14 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY CHEMICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 15 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY BIOLOGICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 16 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER PHARMACEUTICAL SERVICES, 2019-2027 ($ MILLION) FIGURE 17 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION) FIGURE 18 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY PHARMACEUTICAL COMPANIES, 2019-2027 ($ MILLION) FIGURE 19 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), 2019-2027 ($ MILLION) FIGURE 20 ASIA-PACIFIC DRUG DISCOVERY MARKET, BY OTHER END-USERS, 2019-2027 ($ MILLION) FIGURE 21 CHINA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 22 INDIA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 23 JAPAN DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 24 SOUTH KOREA DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 25 AUSTRALIA & NEW ZEALAND DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 26 ASEAN COUNTRIES DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION) FIGURE 27 REST OF ASIA-PACIFIC DRUG DISCOVERY MARKET, 2019-2027 ($ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Other Reports by Triton Market Research

THE UNITED STATES HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The market for hair care in the United States is projected to expand with 1.14% of CAGR in the forecasting period of 2019-2025. The “ethnic hair care” category in the US is going through a massive shift. The sales of relaxants have...

INDIA HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The market for hair care in India has been anticipated to upsurge with 1.57% of CAGR in the forecasting years of 2019-2025. The middle-class population formed a significant consumer base for hair care products in the India market; this...

FRANCE HAIR CARE MARKET 2019-2025

MARKET OUTLOOK Triton Market Research speculates the France hair care market to witness -0.10% of CAGR during the forecast years of 2019-2025. The mature hair care category continued to be affected by pressure on prices, particularly in the mass dist...

CHINA HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The China hair care market is expected to display an upward trend and is estimated to grow at a CAGR of 0.94% in terms of revenue over the forecast duration of 2019 to 2025. With increasing public awareness for personal grooming and th...

BRAZIL HAIR CARE MARKET 2019-2025

MARKET OUTLOOK The Brazilian hair care market is expected to proliferate at a CAGR of 3.18% during the forecasting period between 2019 and 2025. Salon hair care in Brazil has witnessed fast growth. Despite registering a volume decline, this category ...

Publisher: Triton Market Research